Baird Medical Investment Holdings Ltd. $(BDMD)$, a leader in Microwave Ablation $(MWA)$ technology, has announced the establishment of a dedicated manufacturing base in the United States. This significant move marks Baird Medical's transition from a specialized exporter to a comprehensive global medical technology enterprise, supporting its global expansion and future research and development initiatives.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baird Medical Investment Holdings Ltd. published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.